vs

Side-by-side financial comparison of HUTCHMED (China) Ltd (HCM) and TOMPKINS FINANCIAL CORP (TMP). Click either name above to swap in a different company.

HUTCHMED (China) Ltd is the larger business by last-quarter revenue ($270.8M vs $194.8M, roughly 1.4× TOMPKINS FINANCIAL CORP). TOMPKINS FINANCIAL CORP runs the higher net margin — 49.4% vs 0.7%, a 48.7% gap on every dollar of revenue. On growth, TOMPKINS FINANCIAL CORP posted the faster year-over-year revenue change (152.7% vs -16.5%). TOMPKINS FINANCIAL CORP produced more free cash flow last quarter ($31.9M vs $3.4M).

HUTCHMED (China) Ltd is a biopharmaceutical firm focused on discovering, developing and commercializing targeted and immunotherapies for oncology and immunological diseases. It operates across China and global markets, with multiple marketed oncology drugs and a robust pipeline of late-stage clinical candidates addressing unmet patient needs.

Tompkins Financial Corporation is a small, diversified financial services company based in Ithaca, New York. It is the parent of the Tompkins Trust Company, as well as several other banks, an insurance agency, and a wealth management division.

HCM vs TMP — Head-to-Head

Bigger by revenue
HCM
HCM
1.4× larger
HCM
$270.8M
$194.8M
TMP
Growing faster (revenue YoY)
TMP
TMP
+169.2% gap
TMP
152.7%
-16.5%
HCM
Higher net margin
TMP
TMP
48.7% more per $
TMP
49.4%
0.7%
HCM
More free cash flow
TMP
TMP
$28.6M more FCF
TMP
$31.9M
$3.4M
HCM

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
HCM
HCM
TMP
TMP
Revenue
$270.8M
$194.8M
Net Profit
$2.0M
$96.2M
Gross Margin
37.7%
Operating Margin
-13.2%
71.7%
Net Margin
0.7%
49.4%
Revenue YoY
-16.5%
152.7%
Net Profit YoY
-83.6%
388.9%
EPS (diluted)
$0.00
$6.72

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
HCM
HCM
TMP
TMP
Q4 25
$270.8M
$194.8M
Q3 25
$87.4M
Q2 25
$277.7M
$82.6M
Q1 25
$324.5M
$81.7M
Q4 24
$77.1M
Q3 24
$76.6M
Q2 24
$305.7M
$72.7M
Q1 24
$72.8M
Net Profit
HCM
HCM
TMP
TMP
Q4 25
$2.0M
$96.2M
Q3 25
$23.7M
Q2 25
$455.0M
$21.5M
Q1 25
$11.9M
$19.7M
Q4 24
$19.7M
Q3 24
$18.6M
Q2 24
$25.8M
$15.7M
Q1 24
$16.9M
Gross Margin
HCM
HCM
TMP
TMP
Q4 25
37.7%
Q3 25
Q2 25
0.1%
Q1 25
48.0%
Q4 24
Q3 24
Q2 24
41.1%
Q1 24
Operating Margin
HCM
HCM
TMP
TMP
Q4 25
-13.2%
71.7%
Q3 25
35.6%
Q2 25
-1.3%
34.2%
Q1 25
-5.0%
31.6%
Q4 24
33.4%
Q3 24
32.0%
Q2 24
-9.0%
28.3%
Q1 24
30.4%
Net Margin
HCM
HCM
TMP
TMP
Q4 25
0.7%
49.4%
Q3 25
27.1%
Q2 25
163.8%
26.0%
Q1 25
3.7%
24.1%
Q4 24
25.5%
Q3 24
24.3%
Q2 24
8.4%
21.6%
Q1 24
23.2%
EPS (diluted)
HCM
HCM
TMP
TMP
Q4 25
$0.00
$6.72
Q3 25
$1.65
Q2 25
$0.52
$1.50
Q1 25
$0.01
$1.37
Q4 24
$1.39
Q3 24
$1.30
Q2 24
$0.03
$1.10
Q1 24
$1.18

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
HCM
HCM
TMP
TMP
Cash + ST InvestmentsLiquidity on hand
$1.4B
$132.8M
Total DebtLower is stronger
$93.2M
Stockholders' EquityBook value
$1.2B
$938.4M
Total Assets
$1.8B
$8.7B
Debt / EquityLower = less leverage
0.08×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
HCM
HCM
TMP
TMP
Q4 25
$1.4B
$132.8M
Q3 25
$193.5M
Q2 25
$1.4B
$212.6M
Q1 25
$836.1M
$193.1M
Q4 24
$134.4M
Q3 24
$132.3M
Q2 24
$802.5M
$70.9M
Q1 24
$57.1M
Total Debt
HCM
HCM
TMP
TMP
Q4 25
$93.2M
Q3 25
Q2 25
$93.4M
Q1 25
$82.8M
Q4 24
Q3 24
Q2 24
$82.1M
Q1 24
Stockholders' Equity
HCM
HCM
TMP
TMP
Q4 25
$1.2B
$938.4M
Q3 25
$788.8M
Q2 25
$1.2B
$761.8M
Q1 25
$759.9M
$741.4M
Q4 24
$713.4M
Q3 24
$719.9M
Q2 24
$740.1M
$674.6M
Q1 24
$667.9M
Total Assets
HCM
HCM
TMP
TMP
Q4 25
$1.8B
$8.7B
Q3 25
$8.5B
Q2 25
$1.8B
$8.4B
Q1 25
$1.3B
$8.2B
Q4 24
$8.1B
Q3 24
$8.0B
Q2 24
$1.3B
$7.9B
Q1 24
$7.8B
Debt / Equity
HCM
HCM
TMP
TMP
Q4 25
0.08×
Q3 25
Q2 25
0.08×
Q1 25
0.11×
Q4 24
Q3 24
Q2 24
0.11×
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
HCM
HCM
TMP
TMP
Operating Cash FlowLast quarter
$8.2M
$38.9M
Free Cash FlowOCF − Capex
$3.4M
$31.9M
FCF MarginFCF / Revenue
1.2%
16.4%
Capex IntensityCapex / Revenue
1.8%
3.6%
Cash ConversionOCF / Net Profit
4.21×
0.40×
TTM Free Cash FlowTrailing 4 quarters
$-96.2M
$105.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
HCM
HCM
TMP
TMP
Q4 25
$8.2M
$38.9M
Q3 25
$34.9M
Q2 25
$-72.9M
$18.9M
Q1 25
$40.3M
$22.2M
Q4 24
$95.0M
Q3 24
$21.2M
Q2 24
$-39.8M
$27.3M
Q1 24
$23.2M
Free Cash Flow
HCM
HCM
TMP
TMP
Q4 25
$3.4M
$31.9M
Q3 25
$33.9M
Q2 25
$-82.2M
$18.3M
Q1 25
$32.5M
$20.9M
Q4 24
$88.8M
Q3 24
$18.9M
Q2 24
$-49.9M
$26.3M
Q1 24
$21.9M
FCF Margin
HCM
HCM
TMP
TMP
Q4 25
1.2%
16.4%
Q3 25
38.8%
Q2 25
-29.6%
22.1%
Q1 25
10.0%
25.5%
Q4 24
115.1%
Q3 24
24.7%
Q2 24
-16.3%
36.2%
Q1 24
30.0%
Capex Intensity
HCM
HCM
TMP
TMP
Q4 25
1.8%
3.6%
Q3 25
1.1%
Q2 25
3.3%
0.8%
Q1 25
2.4%
1.7%
Q4 24
8.1%
Q3 24
2.9%
Q2 24
3.3%
1.3%
Q1 24
1.9%
Cash Conversion
HCM
HCM
TMP
TMP
Q4 25
4.21×
0.40×
Q3 25
1.47×
Q2 25
-0.16×
0.88×
Q1 25
3.38×
1.13×
Q4 24
4.82×
Q3 24
1.14×
Q2 24
-1.54×
1.74×
Q1 24
1.38×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons